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Abstract 
Background: Thalamic subregions mediate various cognitive functions, includ-
ing attention, inhibitory response control and decision-making. Such neuronal 
activity is modulated by cholinergic thalamic afferents and deterioration of such 
modulatory signaling had been theorised to contribute to cognitive decline in 
neurodegenerative disorders. However, the thalamic subnuclei and cholinergic 
receptors involved in cognitive functioning remain largely unknown.  
Aims: We investigated whether muscarinic or nicotinic receptors in the medio-
dorsal thalamus (MD) and anterior thalamus (AT) contribute to rats’ perfor-
mance in the 5-choice serial reaction time task (5-CSRTT), which measures 
sustained visual attention and impulsive action.  
Methods: Male Long-Evans rats were trained in the 5-CSRTT and then surgi-
cally implanted with guide cannulae targeting either the MD or AT. Reversible 
inactivation of either the MD or AT were achieved with infusions of the GABAer-
gic agonists muscimol and baclofen prior to behavioural assessment. To inves-
tigate cholinergic mechanisms, we also assessed the behavioural effects of lo-
cally administered nicotinic (mecamylamine) and muscarinic (scopolamine) re-
ceptor antagonists.  
Results: Reversible inactivation of the MD severely impaired discriminative ac-
curacy and response speed, and also increased omissions. Inactivation of the 
AT produced less profound effects, with impaired accuracy at the highest dose. 
In contrast, blocking cholinergic transmission in these regions did not signifi-
cantly affect 5-CSRTT performance. 
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Conclusions/interpretations: These findings show that the MD plays a key 
role in visuospatial attentional performance that is independent of local cholin-
ergic neurotransmission.   
Keywords: Acetylcholine, attention, muscarinic receptors, nicotinic receptors, 
prefrontal cortex, thalamus 
 
Introduction 
The thalamus is segregated into many distinct nuclei based on neural connec-
tivity, as well as functional and neurochemical attributes. These subnuclei con-
tribute to large-scale networks associated with specific aspects of cognitive 
function. In addition to causing mnemonic deficits (Dalrymple-Alford et al., 
2015; Leszczynski and Staudigl, 2016), lesions affecting the thalamus also re-
sult in a range of executive deficits associated with attention, working memory, 
cognitive flexibility and decision-making (Wright et al., 2015; Linley et al., 2016; 
Parnaudeau et al., 2018), these being functions that are likely to depend on 
distinct subregions of the thalamus. In rodents, the mediodorsal (MD) and an-
terior (AT) thalamic nuclei have received significant attention due to their dis-
tinct cortical inputs. For example, the AT is critical for regulating spatial aspects 
of memory performance by virtue of its strong hippocampal connections 
(O’Mara and Aggleton, 2019). In contrast, the MD is thought to be more relevant 
for executive type functions due to its interactions with the prefrontal cortex 
(PFC) (Parnaudeau et al., 2015; Bueno-Junior et al., 2018). Consequently, 
when tested on frontal-type tests associated with sustained and spatially-di-
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vided visual attention, rats with MD lesions increase impulsive, premature re-
sponding, whereas those with AT lesions show no change in most aspects of 
attentional performance (Chudasama and Muir, 2001).  
 The MD and AT also receive a dense cholinergic innervation from the nu-
cleus basalis magnocellularis (NBM) and from various brainstem nuclei includ-
ing the peduncolopontine tegmental (PPTg) and laterodorsal tegmental (LDTg) 
nuclei (Pienaar et al., 2017; Soares et al., 2018). In this regard, cholinergic le-
sions and anticholinergic drugs compromise performance in tasks that assess 
visual attention and signal detection (Risbrough et al., 2002; Harati et al., 2008; 
Cyr et al., 2015; Ljubojevic et al., 2018). Given that the NBM sends direct cho-
linergic input to the PFC, the resulting attentional deficits may reflect reduced 
cholinergic tone in this brain region. However, what remains unknown is 
whether acetylcholine (ACh) receptor signaling in the MD and AT contribute to 
attentional function as well. If cholinergic innervation of the MD and AT differ-
entially affects sustained and selective forms of visual attention, it would sug-
gest that these two thalamic nuclei provide a mechanism by which they can 
potentially modulate prefrontal control of attention. 
In the current study we used the 5-choice serial reaction time task (5-
CSRTT) to assess attentional function in rats following (1) temporary inactiva-
tion of the MD and AT through a local infusion of a drug cocktail consisting of 
muscimol, an agonist for the γ-aminobutyric acid (GABA)A receptor, and baclo-
fen, which acts as an agonist to the GABAA receptor, and also (2) by locally 
microinfusing scopolamine (a muscarinic cholinergic receptor antagonist) and 
mecamylamine (a nicotinic cholinergic receptor antagonist) to block cholinergic 
transmission in the MD and AT in a receptor subtype-specific manner.  
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Methods 
Animals 
Twenty-four male Long-Evans rats (Charles River Ltd., Margate, UK) were ini-
tially used in this study. The animals were housed in groups of 3-4/cage, with a 
reversed light/dark cycle applied (lights off between 7:00 and 19:00 h). Behav-
ioural testing occurred during the dark phase of this cycle. Animals were food 
restricted at 18g of laboratory pellet chow once a day post training/testing, but 
with ad libitum access to water. The rats’ weights were monitored to remain 
above 85% of their free-feeding body weight. All experimental procedures com-
plied with the UK Animals’ (Scientific Procedures) Act of 1986 and were ap-
proved by the Local Ethics Review Committee (University of Cambridge, UK). 
Both the Guide for the Care and Use of Laboratory Animals (1996) (National 
Research Council, 2011) and the ARRIVE (Animals in Research: Reporting In 
Vivo Experiments) guidelines (Kilkenny et al., 2010) were followed for all animal 
research procedures performed for the current work. 
Five-choice serial reaction time task  
The five-choice serial reaction time task (5-CSRTT) is a well-validated behav-
ioural paradigm for assessing sustained spatial visual attention in rats (Man-
tanona et al., 2019). The rats were trained and tested in Bussey-Saksida Touch 
System chambers (Lafayette Instrument, Indiana, USA) controlled by ABET II 
and Whisker control software (Cardinal and Aitken, 2001). Chambers were 
trapezoidal (30 cm height x 35 cm length x 30 cm front end width x 25 cm rear 
end width) with a touch-sensitive liquid-crystal display flat screen placed at the 
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front end. The food magazine was located at the rear end of the chamber and 
dispensed 45 mg reward sugar pellets (Sandown Scientific, Middlesex, UK) 
from an external dispenser. Black Perspex masks, with 5 evenly spaced square 
apertures located basally in the rat's immediate field of vision, were secured in 
front of the touchscreens. 
A standard touchscreen-based 5-CSRTT protocol was followed, as shown 
in Figure 1A and B, and described previously (Nilsson et al., 2016; Bharmal et 
al., 2015; Mantanona et al., 2019). Briefly, animals were trained to nose poke 
into a briefly illuminated, spatially random aperture. The training and baseline 
task ended either after 30 mins or when animals completed 100 trials. At the 
end of the training, the stimulus duration (SD) was set to 0.6 s and the inter-
trial interval (ITI) to 5 s. The variables recorded at each session included: (1) 
number of correct responses; (2) number of incorrect responses; (3) accuracy, 
i.e. number of correct responses divided by the total number of correct and 
incorrect responses; (4) number of omitted responses for all trials where a stim-
ulus was presented; (5) number of premature responses made during the ITI 
for all trials initiated; (6) number of perseverative responses - repeat responses 
made after a correct response; (7) correct response latency - time from stimulus 
presentation until a correct response was made; (8) incorrect response latency 
- time from stimulus presentation until an response was made on incorrect tri-
als, as well as (9) magazine latency - time to collect reward post correct re-
sponse. 
 
 
7 
Surgical procedures 
Animals were anaesthetized with 3-5% isoflurane, vaporized in 2.0 l/min O2. 
Analgesia was provided by subcutaneous administration of 0.2 mg/kg Meloxi-
cam (Metacam®, Boehringer Ingelheim, Bracknell, UK). Individual rats were 
then secured in a stereotaxic frame (Kopf, Tujunga, CA, USA). To prevent hy-
pothermia, rats were placed on a homeostatic heating pad with body tempera-
ture monitoring via rectal sensor. For the surgery, a small, elliptical patch of 
scalp was removed along the midline of the skull to accommodate the cannu-
lae, which were inserted bilaterally. Four stainless steel screws were placed 
into the skull, two lying anterior and two lying posterior to the guide cannula 
insertion sites. After attaining a flat skull position, a dental drill was used to drill 
two bilateral holes through the cranium. Through each hole a stainless-steel 
guide cannula (22 gauge; PlasticsOne, Cleveland, OH, USA) was inserted at a 
24° angle in order to target the MD, using the following stereotaxic coordinates: 
-2.52 mm anteroposterior (AP) to bregma, +/-3.4 mm mediolateral (ML) and -
2.7 mm dorsoventral (DV) from the dura. For targeting the AT we used the co-
ordinates -1.80 mm AP to bregma, +/- 3.4 mm ML and -2.7 mm DV from the 
dura. For holding the cannulae in place, dental acrylic cement was applied 
around the cannulae and screws. Each guide cannula had a dummy cannula 
inserted within the internal lumen and a protective cap, which remained in situ 
until the drug infusions. Post-surgical analgesia (1 mg/kg, Metacam®) was 
orally administered for 3 consecutive days post-surgery. Animals were given at 
least 7 days to recover from the surgery before behavioural training resumed.  
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Drug preparation and infusions 
Once the rats had consistently achieved baseline criteria on the behavioural 
task (≥70% accuracy and ≤20% omissions), vehicle (saline) infusions were 
given to habituate rats to infusions. Testing commenced once all rats reached 
baseline criteria with vehicle infusion. Rats were then tested across three sep-
arate and consecutive Latin Squares, using muscimol/baclofen, scopolamine 
and finally mecamylamine, respectively. One day of re-baseline testing (without 
any drug infusions) was included before each drug treatment regime was initi-
ated. In addition, animals were left for a minimum of 14 days between each 
Latin square; baseline sessions were included during this period to ensure sta-
ble performance. 
The GABAA receptor agonist, muscimol hydrobromide (Sigma-Aldrich, Dor-
set, UK) and baclofen hydrochloride, a GABAB receptor agonist (Sigma-Al-
drich), as well as the muscarinic antagonist scopolamine hydrobromide (Sigma-
Aldrich) and nicotinic antagonist, mecamylamine hydrochloride (Sigma-Aldrich) 
were administered to the rats. All drug solutions were prepared by dissolving 
the drug in physiological saline. Muscimol and baclofen were prepared as a 
cocktail of equimolar amounts of both compounds: either 0.01 nmol or 0.03 
nmol per infusion volume per cerebral hemisphere (a total volume of 0.3 µl was 
given). Scopolamine was initially prepared in concentrations of 3, 6 and 10 
µg/0.3 µl; however, at the highest dose (10 µg scopolamine) performance on 
the task was severely disrupted in both MD and AT-infused rats, hence the final 
Latin Square did not include this dose. Mecamylamine was prepared in con-
centrations of 3, 6 and 10 µg/0.3 µl. Previously published work reporting on 
performance-altering effects seen in rodent behavioural tasks (Mitchell et al., 
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2002; Riekkinen et al., 1995) made use of a similar dose (10 µg/0.3 µl) as which 
comprised the highest dose used in the current study, for both the muscarinic 
and nicotinic antagonists, scopolamine or mecamylamine.  
Drug infusions were made using a syringe pump (Harvard Apparatus UK, 
Cambourne, UK) with two 10 µl Hamilton syringes connected via polythene tub-
ing (0.28 mm inner diameter, 0.61 outer diameter; Smiths Medical, Ashford, 
UK) to the internal cannulae, which extended 3 mm below the guides. After the 
internal cannulae were inserted into the brain, we allowed 60 s before infusions 
began; drug or vehicle was then delivered at a rate of 0.3 µl/min over one mi-
nute. Another 60 s was allowed post-infusion to allow diffusion of the drugs, 
before the internal cannulae were slowly removed and the dummy cannulae 
were returned. Each rat included in the study received a maximum of 24 
infusions (to deliver either the vehicle or drug) for the whole duration of the 
study.  
Histology assessment of cannulae placements 
Following completion of the behavioural experiments, rats were euthanised with 
a lethal dose of sodium pentobarbital (Euthatal®, 200 mg/ml, Merial, UK) before 
being transcardially perfused with 0.01 M phosphate buffered saline (PBS), fol-
lowed by 4% paraformaldehyde (PFA). Brains were harvested and post-fixed 
overnight in 4% PFA, followed by 30% sucrose in 0.01 PBS until brains were 
sufficiently dehydrated. Brains were sectioned coronally at 30 µm thickness and 
then stained with cresyl fast violet (CFV) for labelling neurons containing Nissl 
substance. In brief, the staining procedure involved incubating the slides in 
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0.5% cresyl violet acetate (Sigma-Aldrich) for 3 min, differentiated in 70% ab-
solute ethanol, dehydrated through an ascending graded ethanol series, 
cleared in xylene, and finally cover-slipped. From the histology slides we con-
firmed the cannula placements, by consulting a rat brain atlas (Paxinos and 
Watson, 2004), with such assessments performed by an investigator blind to 
the treatment of the rats.  
Statistical analysis 
Data analysis for number of trials, accuracy, errors of omission, premature re-
sponses, number of perseverative responses and latencies were conducted 
using SPSS statistical software (v. 24, SPSS Inc., Chicago, IL, USA). Normality 
of residuals were assessed using Q-Q plots and Shapiro-Wilks test. Non-nor-
mally distributed data were transformed appropriately using arcsine, square 
root and logarithmic transformations (Winer, 1971). Mauchly’s Sphericity Test 
was used to assess homogeneity of variance across data sets. If data sets vi-
olated this requirement, data were transformed, as detailed in the results sec-
tion, with a conservative Greenhouse-Geisser correction used to correct de-
grees of freedom. A mixed effects ANOVA was used to analyse the within-sub-
ject effects of drug dose, the between-subject effects of brain region and the 
dose × brain region interactions. Post-hoc analyses were carried out using the 
Bonferroni correction for multiple comparisons. Power estimates are shown in 
Supplementary Table 1. Throughout, p < 0.05 was considered significant. Data 
are expressed as mean ± standard error of the mean (SEM). Five rats were 
excluded from surgery and further testing due to their inability to maintain a 
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stable level of performance. A further three rats were excluded due to an ina-
bility to reach criteria performance after surgery. In addition, one rat died of 
unknown causes in the home cage before surgery.  
Results 
Histological assessment revealed that cannula tips were distributed uniformly 
in the medial, central and lateral regions of the MD. Cannula tips in the group 
of rats in which the AT had been inactivated were largely restricted to the an-
terodorsal thalamus, the dorsomedial aspect of the anteroventral thalamus and 
the stria medullaris. Representative CFV-stained sections are depicted in Fig. 
2A and 2B, to illustrate placement of cannulation and injection needle tracks for 
targeting the AT and MD in the rats.  
Inactivation of MD produce marked deficits in visuospatial at-
tention 
Inactivation of the MD (n=7) had a large impact on rats’ performance in the 5-
CSRTT relative to inactivation of the AT (n=8) (Fig. 3). One major change be-
tween the two groups was the number of trials completed (Dose × Region in-
teraction; F(2, 26)=9.449; p = 0.001; square root transformation). Those rats 
with MD inactivations completed fewer trials at both the low (0.01 nmol; p = 
0.001) and high (0.03 nmol; p < 0.001) Dose (Fig. 3A). In contrast, inactivating 
the AT had no such effect on trials completed (p > 0.1). Consequently, all further 
analyses were adjusted for total trials initiated or completed, as appropriate. 
The effect of muscimol/baclofebn treatment on accuracy depended on the 
thalamic subregion being targeted (Fig. 3B), indicated by the Dose x Region 
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interaction (F(2, 26)= 5.852, p = 0.008). Post-hoc analysis confirmed that MD 
inactivations reduced accuracy at both low (p = 0.001) and high (p < 0.001) 
doses of muscimol/baclofen, whereas AT inactivations only impaired accuracy 
at the high dose (p = 0.041). Accompanying the reduced accuracy was an in-
crease in the percentage omissions (Dose × Region interaction: F(1.411, 
18.356)=4.565, p = 0.035; arcsine root transformation) (Fig. 3C) exhibited by 
the MD-inactivated group; such animals showed a percentage of omissions fol-
lowing both low (p = 0.030) and high (p = 0.002) doses of muscimol/baclofen. 
This effect was not detected following intra-AT infusions (p > 0.1).  
Muscimol/baclofen treatment produced a main effect of Dose, revealed as 
increase in the percentage premature responses (F(2, 26)=4.418, p = 0.022; 
arcsine root transformation) shown by both the MD and AT groups, but no sig-
nificant Dose × Region interaction (F(2, 26)=0.343, p > 0.1). Post-hoc analysis 
revealed that the high dose of muscimol/baclofen increased the percentage 
premature responses (p = 0.048) (Fig 3D). The ratio of perseverative responses 
was unaffected by the Dose (F(2, 26)=1.223, p > 0.1; Fig. 3E), while no Dose × 
Region interaction was detected (F(2, 26)=2.692, p > 0.1). 
Muscimol/baclofen-mediated thalamic inactivation did not alter the latency 
to collect reward, in accordance to the given dose (F(2, 26)=2.038, p > 0.1; 
logarithmic transformation) (Fig. 3F) for either the MD- or AT-inactivated group, 
with no Dose × Region interaction seen (F(2, 26)=0.723, p > 0.1). Correct re-
sponse latencies increased as a main effect of Dose (F(2, 26)=3.981, p = 0.031; 
logarithmic transformation) (Fig. 3G); however, no significant Dose × Region 
interaction was seen, especially at the high dose (p = 0.059). In addition, incor-
rect response latency analysis revealed a Dose × Region interaction (F(2, 
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26)=4.321, p = 0.024; logarithmic transformation) (Fig. 3H). Post-hoc analysis 
confirmed that the increase in this incorrect latency occurred in the MD-inacti-
vated group at the high dose only (p = 0.037).  
Cholinergic receptor antagonism of the MD and AT does not 
affect attention  
One rat from the MD group was removed from all further cholinergic manipula-
tions due to consistently poor baseline performance. Microinfusions of the mus-
carinic ACh receptor antagonist, scopolamine, into the MD (n=6) and AT (n=8) 
caused no significant change in the animals’ performance. Figure 4A shows 
that scopolamine did not affect the number of trials completed (F(1.365, 
16.385)=2.723, p > 0.1; square root transformation); Dose × Region interaction: 
F(1.365, 16.385)= 0.267, p > 0.1). Other parameters were also not affected for 
either group, including performance accuracy (main effect of Dose: F(2, 
24)=1.895, p > 0.1; Dose × Region interaction: F(2, 24)=0.317, p > 0.1) (Fig. 
4B) and percentage omitted responses (main effect of Dose: F(2, 24)=2.098, p 
> 0.1; Dose × Region interaction: F(2, 24)=2.446, p > 0.1) (Fig. 4C). Parameters 
reflecting inhibitory control were also unaffected for both MD and AT microin-
fused rats. These included percentage premature responses (main effect of 
Dose: F(2, 24)=1.097, p > 0.1; Dose × Region interaction: F(2, 24)=1.100, p > 
0.1) (Fig. 4D) and the correct response ratio (main effect of Dose: F(2, 
24)=0.844, p > 0.1); Dose × Region interaction: F(2, 24)=1.708, p > 0.1) (Fig. 
4E). 
In addition, scopolamine did not affect magazine latencies (main effect of 
dose: F(2, 24)=0.836, p > 0.1; Dose × Region interaction F(2, 24)=2.276, p > 
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0.1; logarithmic transformation) (Fig. 4F), although it did slow correct responses 
in both the MD and AT groups (F(2, 24)=7.755, p = 0.003); logarithmic trans-
formation) (Fig. 4G) at the highest dose (p = 0.026). However, there was no 
scopolamine on incorrect response latencies; F(2, 24)=1.885, p > 0.1; Dose × 
Region interaction: F(2, 24)=1.855, p > 0.1) (Fig. 4H).  
The nicotinic receptor antagonist, mecamylamine, was also largely devoid 
of effects on the 5-CSRTT, regardless of the site of infusion. (Fig. 5). As shown 
in Fig. 5A, all rats, irrespective of infusion site, completed the maximum of 100 
trials following mecamylamine infusions. One rat from the MD group was ex-
cluded because it failed to complete the counterbalanced sequence of meca-
mylamine and vehicle infusions leaving a sample size of n=5. 
Mecamylamine infusions into the MD (n=5) and AT (n=8) did not affect ac-
curacy (main effect of Dose: F3,33 = 0.780, p > 0.1; Dose × Region interaction: 
F3,33 = 1.309, p > 0.1) (Fig. 5B) nor percentage omitted responses (main effect 
of Dose: F3,33 = 0.413, p > 0.1; Dose × Region interaction: F3,33 = 0.840, p > 0.1) 
(Fig. 5C). However, there was a main effect of Dose on percentage premature 
responses (F3,33 = 3.361, p = 0.030), in the absence of a significant Dose × 
Region interaction (F3,33 = 1.158, p > 0.1), while no significant effects were ob-
served in post-hoc analysis when combining MD and AT grouped animals re-
ceiving the highest mecamylamine dose (p = 0.153) (Fig. 5D). Yet, visual in-
spection of the data suggests that mecamylamine administration increased the 
number of premature responses, with the MD group appearing more affected 
than the AT rats. In addition, mecamylamine did not affect perseverative re-
sponses at any level (main effect of Dose: F(3, 33)=0.417, p > 0.1; Dose × Re-
gion interaction F(3, 33)=1.367, p > 0.1; Fig. 5E). 
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Mecamylamine infusions did not affect several others aspects of perfor-
mance including reward latency (main effect of Dose: F(3, 33)=1.996, p > 0.1; 
Dose × Region interaction: F(3, 33)=0.694, p > 0.1) (Fig. 5F), correct response 
latency (main effect of Dose: F(3, 33)=0.502, p > 0.1; Dose × Region interaction: 
F(3, 33)=0.399, p > 0.1) (Fig. 5G), nor incorrect response latency (main effect 
of Dose: F(3, 33)=0.535, p > 0.1; Dose × Region interaction: F(3, 33)=0.298, p 
> 0.1) (Fig. 5I). 
Discussion 
In this study, we investigated performance in a touchscreen version of the 5-
CSRTT following temporary inactivation of two associative thalamic nuclei, the 
MD and AT, and compared it with cholinergic antagonism of the muscarinic and 
nicotinic receptors using scopolamine or mecamylamine, respectively. Inacti-
vating the MD severely disrupted discriminative accuracy as well as the speed 
and vigor of attentional performance. This was in marked contrast to inactiva-
tion of the AT, which produced only minor effects in performance that paralleled 
the lack of effects of nicotinic and muscarinic receptor antagonism in the MD 
and AT. The profile of deficits observed after MD inactivation indicates a critical 
role of this region in multiple aspects of visual attentional performance, rather 
than a specific effect on attention per se. These data emphasize an important 
role for the MD in visual attention but discount a major contribution of choliner-
gic inputs to this region during active attentional performance.  
 MD and visual attention 
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Pharmacological inactivation of the MD severely disrupted visual attention in 
the 5-CSRTT, manifested as a sharp decline in accuracy and an increased 
number of omitted trials, consistent with grossly impaired attention. However, 
response latencies were also impaired (slowed), indicating a more general im-
pairment in attentional performance rather than deficient stimulus detection. 
Nevertheless, since reward collection latencies were unaffected, motor func-
tioning and some aspects of incentive motivation appear to be less dependent 
on the MD. These findings were in marked contrast to the effects of AT inacti-
vation, which disrupted accuracy only at the highest dose tested.  
 The putative role of the MD thalamus in attentional function is supported by 
research in animals (e.g. Ouhaz et al., 2015; 2018) and human imaging studies 
(e.g. Giraldo-Chica et al., 2018; Huang et al., 2019). The current data are con-
sistent with previous work (Chudasama and Muir, 2001; Prasad et al., 2013), 
showing that either lesions of the MD or other forms of MD inactivation in-
creases premature responses. In these studies, rodent behaviour was meas-
ured using the 5-CSRTT and rodent psychomotor vigilance test, in which in-
creased premature responses, as a manifestation of poor impulse control, as-
sociates strongly with attentional impairment. A plausible explanation for the 
lack of effect on visual attention tasks in the Chudasama and Muir (2001) study 
is the chronic nature of excitotoxic lesions used by these investigators, which 
could theoretically allow compensatory mechanisms to rescue 5-CSRTT per-
formance. Using instead a transient inactivation method, i.e. brain region-spe-
cific microinfusions of muscimol and baclofen, the current study provides evi-
dence for a critical role of the MD in visual attention processes.   
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Potential role for MD-PFC interactions in visual attention 
The MD sends dense projections to the PFC, specifically the cingulate cortex 
and lateral orbitofrontal cortex (OFC) (Parnaudeau et al., 2015). These projec-
tions contribute to cortico-thalamo-cortical circuits, with the PFC sending pro-
jections to the MD, while the cortico-thalamic neurons, in turn, receiving direct 
synaptic input from thalamo-cortical neurons. However, they can also be con-
strued as being part of cortico-striatal-thalamo-cortical loops, with a critical in-
volvement in cognitive functions dependent on the PFC (Peters et al., 2016; 
Collins et al., 2018; Mitchell, 2015). Functional evidence in support of the roles 
of thalamocortical pathways in cognition include enhanced thalamocortical syn-
chrony in mice performing working-memory tasks (Parnaudeau et al., 2015) 
and evidence that the PFC recruits the MD to enhance attentional control 
(Schmitt et al., 2017).   
Lesions to the anterior cingulate cortex decrease accuracy whilst increas-
ing omissions in the 5-CSRTT, whereas OFC lesions increase omissions with-
out affecting accuracy (Koike et al., 2016; Mar et al., 2011). It can be specu-
lated, therefore, that MD inactivation, as seen in the present study, impaired 
visual attention by disrupting thalamo-cortical circuits linking the MD with sev-
eral fronto-cortical regions. In contrast, connectivity of the AT with, for example, 
the hippocampus, appears to be less important for visual attentional processing 
in the 5-CSRTT.  
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Cholinergic manipulations do not affect measures of visual at-
tention in the 5-CSRTT 
We observed no significant effect of scopolamine or mecamylamine, on any 
measure of attention (i.e. accuracy or omissions), when either the AT or MD 
was inactivated. The higher doses affected other 5-CSRTT measures, including 
latencies and impulsive action (see below). Thus, despite using otherwise ef-
fective doses of cholinergic agents, we found no evidence for the hypothesis 
that cholinergic input to the thalamus modulates visual attention. This finding is 
at odds with evidence that cholinergic input to the MD is linked to attentional 
function. For example, lesions of the PPTg that deplete the cholinergic inner-
vation of the MD profoundly impair attention performance in the 5-CSRTT (In-
glis et al., 2001; Cyr et al., 2015). Notwithstanding the possibility that PPTg 
lesions also deplete the cholinergic innervation of the PFC, thereby impairing 
attention, MD lesions appear to affect attentional processing via non-cholinergic 
thalamocortical projections (Mar et al., 2011; Ouhaz et al., 2017).  
 Moreover, despite prominent neural projections from the PPTg to the thala-
mus, it is conceivable that cholinergic projections to other brain sites are re-
sponsible for the effects on attention following PPTg lesions. For instance, there 
are PPTg cholinergic fibers both in the striatum and in other dopaminergic nu-
clei of the midbrain (Dautan et al., 2014; Dautan et al., 2016), with such brain 
regions that hold established roles in mediating impulse control (Dalley et al., 
2007) as well as visual attention (Boekhoudt et al., 2017). The NBM in the basal 
forebrain, implicated in aspects of attentional task performance in the 5-
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CSRTT, arguably due to its cholinergic projections to the PFC, also receives 
cholinergic input from the PPTg (Cyr et al., 2015), again implicating cholinergic 
neurons originating from the PPTg in attentional task performance.  
Effects on impulsivity 
Premature responding in the 5-CSRTT significantly increased following reversi-
ble inactivation of the thalamus sub-regions, an effect that was partly recapitu-
lated by mecamylamine. However, the effect was relatively modest and did not 
significantly differ between infusion sites (i.e. there were no dose × brain region 
interactions), indicating that nicotinic signaling in a diffuse area of the thalamus, 
including both the MD and AT, contributes to impulse control. In this context, it 
is worth noting that both MD afferent regions, such as the cingulate cortex and 
AT afferent regions, such as the dorsal hippocampus, have previously been 
linked to premature responses in the 5-CSRTT (Finlay et al., 2015). This could 
suggest that both thalamo-cortical and thalamo-hippocampal circuitry contrib-
ute to impulse control, although it should be noted that excitotoxic lesions to the 
MD, but not the AT, increased premature responding (Chudasama and Muir, 
2001).  
 An area for future studies to explore is the role played by nicotinic ACh re-
ceptors in mediating impulse control within the thalamus. Whereas the present 
data suggests impaired function of this behavioural parameter after blocking 
such receptors, a previous study investigating working memory in rats observed 
that acute and chronic intra-MD infusions of dihydro-β-erythroidine, a α4β2 nic-
otinic receptor antagonist, improved working memory, an effect which is the 
opposite to that seen following similar infusions into the hippocampus and 
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amygdala (Cannady et al., 2009). This improvement was reversed by systemic 
nicotine, as well as by co-infusing the α7 nicotinic receptor antagonist, methyl-
lyaconitine, indicating that α4β2 and α7 may play dissociable roles in modula-
tion of memory by the MD. Similarly, the role of nicotinic ACh receptor subtypes 
in impulse control also remains to be investigated. 
 There are some limitations of our study that merit further discussion. As only 
males were tested it is unclear whether our findings would generalize to female 
rats. However, sex differences in 5-CSRTT performance appear to be relatively 
min (e.g. Anshu et al., 2017) and only apparent when task difficulty is increased 
(Bayless et al., 2012). In addition, no major sex-dependent morphological dif-
ferences have been noted in the rat brain’s cholinergic (Giacobini and Pepeu, 
2018), while, to the best of our knowledge, sexually dimorphic differences in 
cholinergic function have not been reported in the thalamus. Thus, it is unlikely 
that our present findings would be markedly different in female rats; however 
further investigations would be needed to verify this assertion. Rats in the pre-
sent study also received multiple infusions, potentially culminating in local mi-
croglial activation. As microglia express both cholinergic and GABAergic recep-
tors (reviewed by Liu et al., 2016), it is possible that microglia upregulation 
somehow interacted with the locally infused GABAergic and cholinergic agents 
and affected behavioural output. Additional experiments would be required to 
address this possibility, specifically to determine whether the essentially null 
findings reported for the cholinergic antagonists were not due to low statistical 
power for some contrasts (see Supplementary Table 1) or the presence of ac-
21 
tivated microglia in the local vicinity of the infusion sites. Finally, cell-type spec-
ificity within MD and AT could be achieved with genetically engineered tech-
niques such as in vivo optogenetics and chemogenetics.  
Conclusions 
Here we showed that transient, reversible inactivation of the MD, but not the 
AT, significantly impairs sustained visual attention on a touchscreen-based ver-
sion of the 5-CSRTT. Our findings clearly indicate divergent contributions of 
these thalamic subregions in active attentional control and performance, pre-
sumably mediated by MD to PFC connections. Our data indicate that neither 
nicotinic nor muscarinic receptors modulate attentional performance at the level 
of the MD or AT. Nevertheless, transient inactivation of these regions increased 
impulsive responding, an effect that was partly recapitulated by nicotinic recep-
tor antagonism. These findings thus reveal dissociable contributions of two ma-
jor thalamic subregions in visual attentional performance and response inhibi-
tory control.  
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Figure and Supplemental Table Legends: 
 
Figure 1. (A) Experimental sequence for training in the 5-CSRTT and re-
lated drug-testing experiments. (B) A diagram representation of the 5-CSRTT 
test protocol. For 5-CSRTT testing, a trial was initiated when a rat nose-poked 
into the food magazine located at the rear of the chamber. By making a ‘prem-
ature‘ nose-poke prior to stimulus presentation, a time-out punishment was ini-
tiated, consisting of the light being on for 5 s, preventing the rat from performing 
an action, followed by the trial commencing again. Stimulus is presented after 
a 5 s ITI. An ‘incorrect’ nose-poke response initiated a time-out punishment. A 
correct response was rewarded with a sugar pellet in the food magazine. Con-
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tinuous responses into the same correct response aperture prior to reward col-
lection was counted as perseverative responses. The next trial was initiated 
following reward collection.  
 
Figure 2. (A) Representative CFV-stained sections reveal the cannulation 
and injection needle tracks for targeting the AT and MD, (B) corresponding to 
the respective neuro-anatomical schematics (taken from Paxinos and Watson, 
2004) for the AT and MD infusion sites. Confirmed bilateral infusion sites are 
indicated as black dots. In general, inspection of all histologically-stained brain 
sections, representing the cohort of rats used in the current study, showed that 
the brain tissue had recovered well from the repeated drug injection protocols, 
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with no evidence seen of major scar tissue formation (reactive gliosis). Scale 
bar: 400 μm. 
 
Figure 3. Effects of baclofen/muscimol microinfusions into the MD and the 
AT during testing in the 5-CSRTT. Attentional deficits resulted from MD infu-
sions, which manifested as a decrease in (A) trials and (B) accuracy and an 
increase in the (C) percentage responses omitted. (D) Rats in both groups 
showed a trend to respond prior to stimulus presentation following baclo-
fen/muscimol infusions. Such premature responses are interpreted as an index 
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for impulsivity. Although a main effect of treatment was seen in premature re-
sponses, no significant interaction of Dose x Region was found. (E) The ratio 
of perseverative responses:correct responses showed no significant difference 
when comparing treatment groups, indicating that any significant decrease in 
perseverative responses was likely caused by a decrease in correct responses. 
(F) Reward collection latency remained intact in both regions following all mi-
croinfusions. (G) A main effect of Dose was seen on correct response latency, 
but no significant interaction was found. (H) Incorrect response latency was 
increased significantly by the high dose in MD infusions with no other significant 
effects seen for either thalamic regions. Values are shown as mean ± SEM. 
Significance is denoted as *p <0.05, **p < 0.01, ***p < 0.001. Significant main 
effect of Dose-only is denoted as † p <0.05. 
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Figure 4. Effects of scopolamine microinfusions into the MD and AT on 5-
CSRTT performance. No significant effect was produced in (A) the number of 
trials or (B) accuracy of responses. (C) The percentage of omitted responses 
was similarly unaffected in either region by all doses. These results support a 
lack of effect on sustained attention by muscarinic agonism in the MD and AT. 
(D) The percentage premature responses were also left unaffected, with similar 
results for (E) the ratio of perseverative responses:correct responses, indicating 
that scopolamine did not alter aspects of inhibitory control. (F) There was no 
effect on reward collection latency. (G) Scopolamine infusions produced a main 
effect of Dose on correct response latency, but no significant interaction of Dose 
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x Region was seen. (H) Incorrect response latencies were unaffected by infu-
sions into either thalamic region. Significant main effect of Dose-only is denoted 
as p < 0.005. 
 
Figure 5. Effects of mecamylamine infusions into the MD and AT on rats’ 5-
CSRTT performance. No effect was seen in (A) the number of trials completed, 
(B) response accuracy, or (C) the percentage of omitted responses. However, 
the drug was seen to have a significant main effect of Dose on (D) percentage 
premature responses, but this was not accompanied by a significant Dose x 
Region interaction. (E) The ratio of perseverative:correct responses showed no 
significant change from infusions. Similarly, (F) reward collection latency, (G) 
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correct response latency and (H) incorrect response latency remained unaf-
fected, with no significant effect of infusions. Significant main effect of Dose-
only is denoted as † p <0.05. 
Supplemental Table 1. An overview of F statistics, p values and effect sizes 
(partial eta squared) from the main outcomes of the 2-way ANOVA performed 
for each Latin square. Where applicable, the method of transformation em-
ployed is shown.  
 
 
